No immediate trading implications. Monitor future Forms 4 or 5 for actual transactions by Ratcliffe or insiders, which could signal buying or selling interest.
Price Chart
Executive Summary
Ian W. Ratcliffe, a reporting owner at Alamar Biosciences, Inc., filed a Form 3 to report his initial beneficial ownership of securities and appointed Timothy White, Justin J. McAnear, Mike Seater, and Jessie Wang as attorneys-in-fact to file Forms 3, 4, and 5 on his behalf. This is a routine regulatory filing related to Section 16 compliance and does not disclose any changes in ownership or material financial information.
Key Facts
- Ian W. Ratcliffe filed a Form 3 to report initial beneficial ownership of Alamar Biosciences securities.
- He granted a power of attorney to four company executives (Timothy White, Justin J. McAnear, Mike Seater, Jessie Wang) to file SEC Forms 3, 4, and 5 on his behalf.
- The filing does not disclose specific share amounts or transaction details.
- This is a standard compliance filing under Section 16(a) of the Exchange Act.
Financial Impact
No financial impact disclosed
Risk Factors
- None identified from this filing
- Lack of disclosed ownership details limits transparency
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001304782-26-000002 |
| Document: 0001304782-26-000002-index-headers.html | 0001304782-26-000002 |
| Document: 0001304782-26-000002-index.html | 0001304782-26-000002 |
| Document: 0001304782-26-000002.txt | 0001304782-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (+10.83%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.39 (−5.80%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.39 (−7.35%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.39 (−0.33%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.39 (−16.90%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.39 (+10.91%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.39 (+6.93%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.39 (+26.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers